The other day, a company called The Mednet launched its platform that gives physicians a Quora-like knowledge-sharing tool, which provides them with expert answers about the latest research in their field. So far, the site has focused strictly on cancer.

The information provided is not case-based due to rules governing medical information and patients’ privacy. Instead, it is situation-based, meaning doctors are not able to share patient data, not even blurred photos.

The New York City-based company has been developing the platform for about 2.5 years, and has just launched as part of the latest batch of the Y Combinator accelerator. It was co-founded by Nadine Housri, a radiation oncologist, and her brother CEO Samir Housri.

Early feedback has been “inspiring”, according to Nadine, with cancer experts regularly helping each other to figure out complex issues that will immediately impact their patients. For example, a new study published in the prestigious New England Journal of Medicine came out, and an investigator in that study, Howard Sandler, answered questions about it on The Mednet.

Nadine added that when the site first launched, she wasn’t sure if oncologists, professors, department chairs and other cancer researchers would be too busy to give away their expertise on some new online platform. To her surprise, that was a wrong assumption.

“Experts are willing to give away info to random people here because they constantly field phone calls, emails and answer questions at medical conferences anyway. One reason you go into academia or medicine is to have a great impact on people, on your community. On Mednet experts can put their answers out there, clear up misconceptions on research and clinical practices,” she said.

Going forward, The Mednet plans to expand beyond oncology. It is also exploring the potential to generate revenue by helping companies raise awareness of and enroll patients in their clinical trials. Or, it could aggregate some of its expert answers into automated decision support tool for clinics.

The company has raised some grant funding and equity funding to date, including from Y Combinator and The Hope Foundation.